Breast Biopsy Device Market Size, Share | CAGR of 9.2%

<h2>Market Overview</h2>
<p>The Global <strong>Breast Biopsy Device Market</strong> size is expected to be worth around <strong>USD 4.3 Billion</strong> by 2033 from <strong>USD 1.8 Billion</strong> in 2023, growing at a CAGR of <strong>9.2%</strong> during the forecast period from 2024 to 2033.</p>
<p>Breast biopsy serves as a diagnostic procedure employed to ascertain the malignancy of a small tissue sample extracted from the breast. It is regarded as one of the most efficient methods for cancer detection. Approximately 70-80 percent of biopsies yield results indicating the absence of cancer, although they may reveal traits that could potentially predispose to mammary carcinoma. A breast biopsy is recommended when an individual presents symptoms such as a breast lump, breast soreness, dimpling of the breast, peeling skin on the breast, or nipple discharge.</p>
<p>On January 30, 2020, the World Health Organization (WHO) officially declared the COVID-19 outbreak a global public health emergency. The coronavirus has had an impact on approximately 210 countries worldwide. In response to the COVID-19 pandemic, governments around the world implemented widespread lockdowns and social distancing measures to prevent the <a href="https://market.us/reports/healthcare/">healthcare</a> system from becoming overwhelmed. States also imposed restrictions and guidelines on non-essential surgeries and activities.</p>
<p>The market is witnessing growth due to technological enhancements and advancements in <a href="https://market.us/report/breast-biopsy-devices-market/">breast biopsy</a> tools. Nevertheless, the high cost of breast biopsy and the numerous adverse side effects associated with it could constrain market expansion. Given the increased prevalence of breast cancer, vendor promotion opportunities have become crucial. Key market players are dedicated to broadening their product portfolios and securing approvals for their offerings. Various platforms, including conferences, can be leveraged to disseminate information and raise awareness about cancer.</p>
<p><img class="alignnone size-full wp-image-113091" src="https://market.us/wp-content/uploads/2022/06/Breast-Biopsy-Device-Market-Size.jpg" alt="Breast Biopsy Device Market Size" width="1217" height="749"></p>

<h2>市场概览</h2>
<p>全球乳腺活检设备市场规模预计到2033年将达到约<strong>43亿美元</strong>，从2023年的<strong>18亿美元</strong>增长，在2024年至2033年预测期间以年均复合增长率（CAGR）<strong>9.2%</strong>增长。</p>
<p>乳腺活检是一种诊断程序，用于确定从乳腺中提取的小组织样本的恶性程度。它被认为是癌症检测中最有效的方法之一。大约70-80%的活检结果指示无癌，尽管它们可能揭示出可能导致乳腺癌的潜在特征。当个体出现乳腺肿块、乳腺疼痛、乳腺凹陷、乳腺皮肤脱落或乳头溢液等症状时，建议进行乳腺活检。</p>
<p>2020年1月30日，世界卫生组织（WHO）正式宣布COVID-19疫情为全球公共卫生紧急事件。新冠病毒影响了全球大约210个国家。为应对COVID-19大流行，世界各国实施了广泛的封锁和社交距离措施，以防止医疗系统不堪重负。各州也对非必要手术和活动实施了限制和指导方针。</p>
<p>市场得益于技术的提升和乳腺活检工具的进步而增长。然而，乳腺活检的高成本及其诸多不良副作用可能会限制市场扩张。鉴于乳腺癌发病率的增加，供应商的推广机会变得至关重要。主要市场参与者致力于扩大其产品组合并获得其产品的批准。可以通过包括会议在内的各种平台来传播信息并提高对癌症的认识。</p>
<p><img class=